Jaclyn Lyman, MSc

Jaclyn Lyman earned her MSc of integrated immunology at the University of Oxford; she sustains a deep interest in immunotherapy, particularly in the realm of oncology. She has six years' experience working in clinical trial management at Memorial Sloan Kettering Cancer Center in New York.

Most Recent Articles by Jaclyn Lyman, MSc

Clinical Trial Reporting in the United States: Limitations of Strained Resources

Clinical Trial Reporting in the United States: Limitations of Strained Resources

By

Guidelines and technology are changing, but as the number of clinical trials increases, ensuring that trials are reported will be an increasingly difficult task.

Relationship Between Mutant KRAS and ACLS3 Opens Door to Therapy Development for NSCLC

Relationship Between Mutant KRAS and ACLS3 Opens Door to Therapy Development for NSCLC

By

Research has uncovered a potential treatment target for mutant KRAS non-small cell lung cancer: Acyl-Coenzyme A synthetase long chain family member 3.

The Future of the Biomedical Research Workforce in the United States

The Future of the Biomedical Research Workforce in the United States

By

As our aging workforce expands, a decreasing number of young investigators are applying for National Institute of Health (NIH) R01-equivalent grants.

Research Suggests That Multiple Myeloma Is Heritable

Research Suggests That Multiple Myeloma Is Heritable

By

Oncologists may be on the path towards elucidating clinically translatable etiologies of MM.

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs

Sign Up for Free e-newsletters